Table 2.
Immunophenotypes in reported cases of plasmablastic lymphoma in transplanted patients
| Study | VS38c | CD79a | CD20 | κ | λ | EBER | CD138 | CD56 | IgG | IgM | CD30 | EMA | LCA | HHV-8 | Ki-67 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nicol et al, 2003 (4) | 1/1 | 0/1 | 0/1 | 0/1 | – | – | 0/1 | 0/1 | 1/1 | – | – | 0/1 | – | – | – | |
| Teruya-Feldstein et al, 2004 (19) | – | 0/1 | 0/1 | – | – | 1/1 | 1/1 | – | – | – | – | – | Weak | 1/1 | – | >80% |
| Verma et al, 2005 (20) | – | 1/1 | 0/1 | 0/1 | 1/1 | 1/1 | – | 1/1 | – | – | 0/1 | – | – | 1/1 | – | |
| Borenstein et al, 2007 (21) | 4/4 | Weak | 4/4 | 0/4 | 2/4 | 1/4 | 3/4 | 2/3 | 0/3 | – | – | 1/2 | 1/3 | – | – | 70%–90% |
| Apichai and Hernandez et al, 2009 (22, 23) | – | Weak 1/1 | 0/1 | 0/1 | 1/1 | – | 1/1 | 1/1 | – | – | 0/1 | – | – | – | >90% | |
| Zimmermann et al, 2012 (24) | – | – | 0/7 | 4/7 | 2/7 | 5/8 | 6/8 | 1/6 | – | – | – | – | – | – | 80%–100% | |
| Present study (including Shahriar et al, 2012 [5]) | – | – | 0/2 | 0/2 | 0/2 | 2/2 | 2/2 | 2/2 | – | – | 0/2 | – | – | – | – |
κ indicates kappa; λ, lambda; EBER, Epstein-Barr virus early RNA; EMA, epithelial membrane antigen; LCA, leukocyte common antigen; HHV-8, human herpes virus-8.